Medical Care
Global Stem Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 159752
- Pages: 115
- Figures: 120
- Views: 47
The global Stem Cells market size was US$ 3381 million in 2024 and is forecast to a readjusted size of US$ 6906 million by 2031 with a CAGR of 10.9% during the forecast period 2025-2031.
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Stem cell industry of the world"s major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
The global Stem Cells market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
By Type: (Dominant Segment vs High-Margin Innovation)
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
By Application: (Core Demand Driver vs Emerging Opportunity)
Blood Disease
Cancer
Autoimmune Disease
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Osiris Therapeutics in Europe)
- Emerging Product Trends: Stem Cell Storage adoption vs. Stem Cell Pharmaceutical and Treatment premiumization
- Demand-Side Dynamics: Blood Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Stem Cells market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Stem Cell Pharmaceutical and Treatment in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Stem Cells value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: Embryos formed during the blastocyst phase of embryological development (embryonic stem cells) and Adult tissue (adult stem cells).
Stem cell industry of the world"s major players have Osiris Therapeutics, NuVasive, Chiesi Pharmaceuticals, Medi - post, JCR Pharmaceutical, MolMed, Pharmicell, Anterogen, Takeda (TiGenix), CBR, ViaCord, Esperite, LifeCell, CCBC, VCANBIO, BOYA LIFE, Beike Biotechnology and International Medical, etc, It has a total market share of 45%.
The global Stem Cells market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Osiris Therapeutics
NuVasive
Chiesi Pharmaceuticals
Medi-post
JCR Pharmaceutical
MolMed
Pharmicell
Anterogen
Takeda (TiGenix)
CBR
ViaCord
Esperite
LifeCell
CCBC
VCANBIO
BOYA LIFE
Beike Biotechnology
International Medical
Global Cord Blood Corporation
Beijing Health-Biotech Group
ABMD
By Type: (Dominant Segment vs High-Margin Innovation)
Stem Cell Storage
Stem Cell Pharmaceutical and Treatment
By Application: (Core Demand Driver vs Emerging Opportunity)
Blood Disease
Cancer
Autoimmune Disease
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Osiris Therapeutics in Europe)
- Emerging Product Trends: Stem Cell Storage adoption vs. Stem Cell Pharmaceutical and Treatment premiumization
- Demand-Side Dynamics: Blood Disease growth in China vs. Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Stem Cells market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Stem Cell Pharmaceutical and Treatment in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Cancer in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Stem Cells value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cells Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Stem Cells Revenue Market Share by Region (2020-2025)
2.4 Global Stem Cells Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Stem Cells Market Size and Prospective (2020-2031)
2.5.2 Europe Stem Cells Market Size and Prospective (2020-2031)
2.5.3 China Stem Cells Market Size and Prospective (2020-2031)
2.5.4 Japan Stem Cells Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Stem Cells Historic Market Size by Type (2020-2025)
3.2 Global Stem Cells Forecasted Market Size by Type (2026-2031)
3.3 Different Types Stem Cells Representative Players
4 Breakdown Data by Application
4.1 Global Stem Cells Historic Market Size by Application (2020-2025)
4.2 Global Stem Cells Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Stem Cells Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Stem Cells Players by Revenue (2020-2025)
5.1.2 Global Stem Cells Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Stem Cells Revenue
5.4 Global Stem Cells Market Concentration Analysis
5.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2024
5.5 Global Key Players of Stem Cells Head office and Area Served
5.6 Global Key Players of Stem Cells, Product and Application
5.7 Global Key Players of Stem Cells, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Stem Cells Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Stem Cells Market Size by Type (2020-2025)
6.1.2.2 North America Stem Cells Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Stem Cells Market Size by Application (2020-2025)
6.1.3.2 North America Stem Cells Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Stem Cells Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Stem Cells Market Size by Type (2020-2025)
6.2.2.2 Europe Stem Cells Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Stem Cells Market Size by Application (2020-2025)
6.2.3.2 Europe Stem Cells Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Stem Cells Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Stem Cells Market Size by Type (2020-2025)
6.3.2.2 China Stem Cells Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Stem Cells Market Size by Application (2020-2025)
6.3.3.2 China Stem Cells Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Stem Cells Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Stem Cells Market Size by Type (2020-2025)
6.4.2.2 Japan Stem Cells Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Stem Cells Market Size by Application (2020-2025)
6.4.3.2 Japan Stem Cells Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Osiris Therapeutics
7.1.1 Osiris Therapeutics Company Details
7.1.2 Osiris Therapeutics Business Overview
7.1.3 Osiris Therapeutics Stem Cells Introduction
7.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2020-2025)
7.1.5 Osiris Therapeutics Recent Development
7.2 NuVasive
7.2.1 NuVasive Company Details
7.2.2 NuVasive Business Overview
7.2.3 NuVasive Stem Cells Introduction
7.2.4 NuVasive Revenue in Stem Cells Business (2020-2025)
7.2.5 NuVasive Recent Development
7.3 Chiesi Pharmaceuticals
7.3.1 Chiesi Pharmaceuticals Company Details
7.3.2 Chiesi Pharmaceuticals Business Overview
7.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
7.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2020-2025)
7.3.5 Chiesi Pharmaceuticals Recent Development
7.4 Medi-post
7.4.1 Medi-post Company Details
7.4.2 Medi-post Business Overview
7.4.3 Medi-post Stem Cells Introduction
7.4.4 Medi-post Revenue in Stem Cells Business (2020-2025)
7.4.5 Medi-post Recent Development
7.5 JCR Pharmaceutical
7.5.1 JCR Pharmaceutical Company Details
7.5.2 JCR Pharmaceutical Business Overview
7.5.3 JCR Pharmaceutical Stem Cells Introduction
7.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2020-2025)
7.5.5 JCR Pharmaceutical Recent Development
7.6 MolMed
7.6.1 MolMed Company Details
7.6.2 MolMed Business Overview
7.6.3 MolMed Stem Cells Introduction
7.6.4 MolMed Revenue in Stem Cells Business (2020-2025)
7.6.5 MolMed Recent Development
7.7 Pharmicell
7.7.1 Pharmicell Company Details
7.7.2 Pharmicell Business Overview
7.7.3 Pharmicell Stem Cells Introduction
7.7.4 Pharmicell Revenue in Stem Cells Business (2020-2025)
7.7.5 Pharmicell Recent Development
7.8 Anterogen
7.8.1 Anterogen Company Details
7.8.2 Anterogen Business Overview
7.8.3 Anterogen Stem Cells Introduction
7.8.4 Anterogen Revenue in Stem Cells Business (2020-2025)
7.8.5 Anterogen Recent Development
7.9 Takeda (TiGenix)
7.9.1 Takeda (TiGenix) Company Details
7.9.2 Takeda (TiGenix) Business Overview
7.9.3 Takeda (TiGenix) Stem Cells Introduction
7.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2020-2025)
7.9.5 Takeda (TiGenix) Recent Development
7.10 CBR
7.10.1 CBR Company Details
7.10.2 CBR Business Overview
7.10.3 CBR Stem Cells Introduction
7.10.4 CBR Revenue in Stem Cells Business (2020-2025)
7.10.5 CBR Recent Development
7.11 ViaCord
7.11.1 ViaCord Company Details
7.11.2 ViaCord Business Overview
7.11.3 ViaCord Stem Cells Introduction
7.11.4 ViaCord Revenue in Stem Cells Business (2020-2025)
7.11.5 ViaCord Recent Development
7.12 Esperite
7.12.1 Esperite Company Details
7.12.2 Esperite Business Overview
7.12.3 Esperite Stem Cells Introduction
7.12.4 Esperite Revenue in Stem Cells Business (2020-2025)
7.12.5 Esperite Recent Development
7.13 LifeCell
7.13.1 LifeCell Company Details
7.13.2 LifeCell Business Overview
7.13.3 LifeCell Stem Cells Introduction
7.13.4 LifeCell Revenue in Stem Cells Business (2020-2025)
7.13.5 LifeCell Recent Development
7.14 CCBC
7.14.1 CCBC Company Details
7.14.2 CCBC Business Overview
7.14.3 CCBC Stem Cells Introduction
7.14.4 CCBC Revenue in Stem Cells Business (2020-2025)
7.14.5 CCBC Recent Development
7.15 VCANBIO
7.15.1 VCANBIO Company Details
7.15.2 VCANBIO Business Overview
7.15.3 VCANBIO Stem Cells Introduction
7.15.4 VCANBIO Revenue in Stem Cells Business (2020-2025)
7.15.5 VCANBIO Recent Development
7.16 BOYA LIFE
7.16.1 BOYA LIFE Company Details
7.16.2 BOYA LIFE Business Overview
7.16.3 BOYA LIFE Stem Cells Introduction
7.16.4 BOYA LIFE Revenue in Stem Cells Business (2020-2025)
7.16.5 BOYA LIFE Recent Development
7.17 Beike Biotechnology
7.17.1 Beike Biotechnology Company Details
7.17.2 Beike Biotechnology Business Overview
7.17.3 Beike Biotechnology Stem Cells Introduction
7.17.4 Beike Biotechnology Revenue in Stem Cells Business (2020-2025)
7.17.5 Beike Biotechnology Recent Development
7.18 International Medical
7.18.1 International Medical Company Details
7.18.2 International Medical Business Overview
7.18.3 International Medical Stem Cells Introduction
7.18.4 International Medical Revenue in Stem Cells Business (2020-2025)
7.18.5 International Medical Recent Development
7.19 Global Cord Blood Corporation
7.19.1 Global Cord Blood Corporation Company Details
7.19.2 Global Cord Blood Corporation Business Overview
7.19.3 Global Cord Blood Corporation Stem Cells Introduction
7.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2020-2025)
7.19.5 Global Cord Blood Corporation Recent Development
7.20 Beijing Health-Biotech Group
7.20.1 Beijing Health-Biotech Group Company Details
7.20.2 Beijing Health-Biotech Group Business Overview
7.20.3 Beijing Health-Biotech Group Stem Cells Introduction
7.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2020-2025)
7.20.5 Beijing Health-Biotech Group Recent Development
7.21 ABMD
7.21.1 ABMD Company Details
7.21.2 ABMD Business Overview
7.21.3 ABMD Stem Cells Introduction
7.21.4 ABMD Revenue in Stem Cells Business (2020-2025)
7.21.5 ABMD Recent Development
8 Stem Cells Market Dynamics
8.1 Stem Cells Industry Trends
8.2 Stem Cells Market Drivers
8.3 Stem Cells Market Challenges
8.4 Stem Cells Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Stem Cell Storage
1.2.3 Stem Cell Pharmaceutical and Treatment
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Blood Disease
1.3.3 Cancer
1.3.4 Autoimmune Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cells Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Stem Cells Revenue Market Share by Region (2020-2025)
2.4 Global Stem Cells Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Stem Cells Market Size and Prospective (2020-2031)
2.5.2 Europe Stem Cells Market Size and Prospective (2020-2031)
2.5.3 China Stem Cells Market Size and Prospective (2020-2031)
2.5.4 Japan Stem Cells Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Stem Cells Historic Market Size by Type (2020-2025)
3.2 Global Stem Cells Forecasted Market Size by Type (2026-2031)
3.3 Different Types Stem Cells Representative Players
4 Breakdown Data by Application
4.1 Global Stem Cells Historic Market Size by Application (2020-2025)
4.2 Global Stem Cells Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Stem Cells Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Stem Cells Players by Revenue (2020-2025)
5.1.2 Global Stem Cells Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Stem Cells Revenue
5.4 Global Stem Cells Market Concentration Analysis
5.4.1 Global Stem Cells Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Stem Cells Revenue in 2024
5.5 Global Key Players of Stem Cells Head office and Area Served
5.6 Global Key Players of Stem Cells, Product and Application
5.7 Global Key Players of Stem Cells, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Stem Cells Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Stem Cells Market Size by Type (2020-2025)
6.1.2.2 North America Stem Cells Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Stem Cells Market Size by Application (2020-2025)
6.1.3.2 North America Stem Cells Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Stem Cells Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Stem Cells Market Size by Type (2020-2025)
6.2.2.2 Europe Stem Cells Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Stem Cells Market Size by Application (2020-2025)
6.2.3.2 Europe Stem Cells Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Stem Cells Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Stem Cells Market Size by Type (2020-2025)
6.3.2.2 China Stem Cells Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Stem Cells Market Size by Application (2020-2025)
6.3.3.2 China Stem Cells Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Stem Cells Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Stem Cells Market Size by Type (2020-2025)
6.4.2.2 Japan Stem Cells Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Stem Cells Market Size by Application (2020-2025)
6.4.3.2 Japan Stem Cells Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Osiris Therapeutics
7.1.1 Osiris Therapeutics Company Details
7.1.2 Osiris Therapeutics Business Overview
7.1.3 Osiris Therapeutics Stem Cells Introduction
7.1.4 Osiris Therapeutics Revenue in Stem Cells Business (2020-2025)
7.1.5 Osiris Therapeutics Recent Development
7.2 NuVasive
7.2.1 NuVasive Company Details
7.2.2 NuVasive Business Overview
7.2.3 NuVasive Stem Cells Introduction
7.2.4 NuVasive Revenue in Stem Cells Business (2020-2025)
7.2.5 NuVasive Recent Development
7.3 Chiesi Pharmaceuticals
7.3.1 Chiesi Pharmaceuticals Company Details
7.3.2 Chiesi Pharmaceuticals Business Overview
7.3.3 Chiesi Pharmaceuticals Stem Cells Introduction
7.3.4 Chiesi Pharmaceuticals Revenue in Stem Cells Business (2020-2025)
7.3.5 Chiesi Pharmaceuticals Recent Development
7.4 Medi-post
7.4.1 Medi-post Company Details
7.4.2 Medi-post Business Overview
7.4.3 Medi-post Stem Cells Introduction
7.4.4 Medi-post Revenue in Stem Cells Business (2020-2025)
7.4.5 Medi-post Recent Development
7.5 JCR Pharmaceutical
7.5.1 JCR Pharmaceutical Company Details
7.5.2 JCR Pharmaceutical Business Overview
7.5.3 JCR Pharmaceutical Stem Cells Introduction
7.5.4 JCR Pharmaceutical Revenue in Stem Cells Business (2020-2025)
7.5.5 JCR Pharmaceutical Recent Development
7.6 MolMed
7.6.1 MolMed Company Details
7.6.2 MolMed Business Overview
7.6.3 MolMed Stem Cells Introduction
7.6.4 MolMed Revenue in Stem Cells Business (2020-2025)
7.6.5 MolMed Recent Development
7.7 Pharmicell
7.7.1 Pharmicell Company Details
7.7.2 Pharmicell Business Overview
7.7.3 Pharmicell Stem Cells Introduction
7.7.4 Pharmicell Revenue in Stem Cells Business (2020-2025)
7.7.5 Pharmicell Recent Development
7.8 Anterogen
7.8.1 Anterogen Company Details
7.8.2 Anterogen Business Overview
7.8.3 Anterogen Stem Cells Introduction
7.8.4 Anterogen Revenue in Stem Cells Business (2020-2025)
7.8.5 Anterogen Recent Development
7.9 Takeda (TiGenix)
7.9.1 Takeda (TiGenix) Company Details
7.9.2 Takeda (TiGenix) Business Overview
7.9.3 Takeda (TiGenix) Stem Cells Introduction
7.9.4 Takeda (TiGenix) Revenue in Stem Cells Business (2020-2025)
7.9.5 Takeda (TiGenix) Recent Development
7.10 CBR
7.10.1 CBR Company Details
7.10.2 CBR Business Overview
7.10.3 CBR Stem Cells Introduction
7.10.4 CBR Revenue in Stem Cells Business (2020-2025)
7.10.5 CBR Recent Development
7.11 ViaCord
7.11.1 ViaCord Company Details
7.11.2 ViaCord Business Overview
7.11.3 ViaCord Stem Cells Introduction
7.11.4 ViaCord Revenue in Stem Cells Business (2020-2025)
7.11.5 ViaCord Recent Development
7.12 Esperite
7.12.1 Esperite Company Details
7.12.2 Esperite Business Overview
7.12.3 Esperite Stem Cells Introduction
7.12.4 Esperite Revenue in Stem Cells Business (2020-2025)
7.12.5 Esperite Recent Development
7.13 LifeCell
7.13.1 LifeCell Company Details
7.13.2 LifeCell Business Overview
7.13.3 LifeCell Stem Cells Introduction
7.13.4 LifeCell Revenue in Stem Cells Business (2020-2025)
7.13.5 LifeCell Recent Development
7.14 CCBC
7.14.1 CCBC Company Details
7.14.2 CCBC Business Overview
7.14.3 CCBC Stem Cells Introduction
7.14.4 CCBC Revenue in Stem Cells Business (2020-2025)
7.14.5 CCBC Recent Development
7.15 VCANBIO
7.15.1 VCANBIO Company Details
7.15.2 VCANBIO Business Overview
7.15.3 VCANBIO Stem Cells Introduction
7.15.4 VCANBIO Revenue in Stem Cells Business (2020-2025)
7.15.5 VCANBIO Recent Development
7.16 BOYA LIFE
7.16.1 BOYA LIFE Company Details
7.16.2 BOYA LIFE Business Overview
7.16.3 BOYA LIFE Stem Cells Introduction
7.16.4 BOYA LIFE Revenue in Stem Cells Business (2020-2025)
7.16.5 BOYA LIFE Recent Development
7.17 Beike Biotechnology
7.17.1 Beike Biotechnology Company Details
7.17.2 Beike Biotechnology Business Overview
7.17.3 Beike Biotechnology Stem Cells Introduction
7.17.4 Beike Biotechnology Revenue in Stem Cells Business (2020-2025)
7.17.5 Beike Biotechnology Recent Development
7.18 International Medical
7.18.1 International Medical Company Details
7.18.2 International Medical Business Overview
7.18.3 International Medical Stem Cells Introduction
7.18.4 International Medical Revenue in Stem Cells Business (2020-2025)
7.18.5 International Medical Recent Development
7.19 Global Cord Blood Corporation
7.19.1 Global Cord Blood Corporation Company Details
7.19.2 Global Cord Blood Corporation Business Overview
7.19.3 Global Cord Blood Corporation Stem Cells Introduction
7.19.4 Global Cord Blood Corporation Revenue in Stem Cells Business (2020-2025)
7.19.5 Global Cord Blood Corporation Recent Development
7.20 Beijing Health-Biotech Group
7.20.1 Beijing Health-Biotech Group Company Details
7.20.2 Beijing Health-Biotech Group Business Overview
7.20.3 Beijing Health-Biotech Group Stem Cells Introduction
7.20.4 Beijing Health-Biotech Group Revenue in Stem Cells Business (2020-2025)
7.20.5 Beijing Health-Biotech Group Recent Development
7.21 ABMD
7.21.1 ABMD Company Details
7.21.2 ABMD Business Overview
7.21.3 ABMD Stem Cells Introduction
7.21.4 ABMD Revenue in Stem Cells Business (2020-2025)
7.21.5 ABMD Recent Development
8 Stem Cells Market Dynamics
8.1 Stem Cells Industry Trends
8.2 Stem Cells Market Drivers
8.3 Stem Cells Market Challenges
8.4 Stem Cells Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Stem Cells Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Stem Cells Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Stem Cells Revenue Share by Region (2020-2025)
Table 6. Global Stem Cells Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Stem Cells Revenue Share Forecast by Region (2026-2031)
Table 8. Global Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Stem Cells Revenue Market Share by Type (2020-2025)
Table 10. Global Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Stem Cells Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Stem Cells Revenue Market Share by Application (2020-2025)
Table 15. Global Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Stem Cells Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Stem Cells Application
Table 18. Global Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Stem Cells Market Share by Players (2020-2025)
Table 20. Global Top Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Table 21. Ranking of Global Top Stem Cells Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Stem Cells, Headquarters and Area Served
Table 24. Global Key Players of Stem Cells, Product and Application
Table 25. Global Key Players of Stem Cells, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Stem Cells Revenue Market Share by Company (2020-2025)
Table 29. North America Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Stem Cells Revenue Market Share by Company (2020-2025)
Table 33. Europe Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Stem Cells Revenue Market Share by Company (2020-2025)
Table 37. China Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Stem Cells Revenue Market Share by Company (2020-2025)
Table 41. Japan Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 43. Osiris Therapeutics Company Details
Table 44. Osiris Therapeutics Business Overview
Table 45. Osiris Therapeutics Stem Cells Product
Table 46. Osiris Therapeutics Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 47. Osiris Therapeutics Recent Development
Table 48. NuVasive Company Details
Table 49. NuVasive Business Overview
Table 50. NuVasive Stem Cells Product
Table 51. NuVasive Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 52. NuVasive Recent Development
Table 53. Chiesi Pharmaceuticals Company Details
Table 54. Chiesi Pharmaceuticals Business Overview
Table 55. Chiesi Pharmaceuticals Stem Cells Product
Table 56. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 57. Chiesi Pharmaceuticals Recent Development
Table 58. Medi-post Company Details
Table 59. Medi-post Business Overview
Table 60. Medi-post Stem Cells Product
Table 61. Medi-post Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 62. Medi-post Recent Development
Table 63. JCR Pharmaceutical Company Details
Table 64. JCR Pharmaceutical Business Overview
Table 65. JCR Pharmaceutical Stem Cells Product
Table 66. JCR Pharmaceutical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 67. JCR Pharmaceutical Recent Development
Table 68. MolMed Company Details
Table 69. MolMed Business Overview
Table 70. MolMed Stem Cells Product
Table 71. MolMed Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 72. MolMed Recent Development
Table 73. Pharmicell Company Details
Table 74. Pharmicell Business Overview
Table 75. Pharmicell Stem Cells Product
Table 76. Pharmicell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 77. Pharmicell Recent Development
Table 78. Anterogen Company Details
Table 79. Anterogen Business Overview
Table 80. Anterogen Stem Cells Product
Table 81. Anterogen Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 82. Anterogen Recent Development
Table 83. Takeda (TiGenix) Company Details
Table 84. Takeda (TiGenix) Business Overview
Table 85. Takeda (TiGenix) Stem Cells Product
Table 86. Takeda (TiGenix) Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 87. Takeda (TiGenix) Recent Development
Table 88. CBR Company Details
Table 89. CBR Business Overview
Table 90. CBR Stem Cells Product
Table 91. CBR Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 92. CBR Recent Development
Table 93. ViaCord Company Details
Table 94. ViaCord Business Overview
Table 95. ViaCord Stem Cells Product
Table 96. ViaCord Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 97. ViaCord Recent Development
Table 98. Esperite Company Details
Table 99. Esperite Business Overview
Table 100. Esperite Stem Cells Product
Table 101. Esperite Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 102. Esperite Recent Development
Table 103. LifeCell Company Details
Table 104. LifeCell Business Overview
Table 105. LifeCell Stem Cells Product
Table 106. LifeCell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 107. LifeCell Recent Development
Table 108. CCBC Company Details
Table 109. CCBC Business Overview
Table 110. CCBC Stem Cells Product
Table 111. CCBC Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 112. CCBC Recent Development
Table 113. VCANBIO Company Details
Table 114. VCANBIO Business Overview
Table 115. VCANBIO Stem Cells Product
Table 116. VCANBIO Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 117. VCANBIO Recent Development
Table 118. BOYA LIFE Company Details
Table 119. BOYA LIFE Business Overview
Table 120. BOYA LIFE Stem Cells Product
Table 121. BOYA LIFE Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 122. BOYA LIFE Recent Development
Table 123. Beike Biotechnology Company Details
Table 124. Beike Biotechnology Business Overview
Table 125. Beike Biotechnology Stem Cells Product
Table 126. Beike Biotechnology Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 127. Beike Biotechnology Recent Development
Table 128. International Medical Company Details
Table 129. International Medical Business Overview
Table 130. International Medical Stem Cells Product
Table 131. International Medical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 132. International Medical Recent Development
Table 133. Global Cord Blood Corporation Company Details
Table 134. Global Cord Blood Corporation Business Overview
Table 135. Global Cord Blood Corporation Stem Cells Product
Table 136. Global Cord Blood Corporation Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 137. Global Cord Blood Corporation Recent Development
Table 138. Beijing Health-Biotech Group Company Details
Table 139. Beijing Health-Biotech Group Business Overview
Table 140. Beijing Health-Biotech Group Stem Cells Product
Table 141. Beijing Health-Biotech Group Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 142. Beijing Health-Biotech Group Recent Development
Table 143. ABMD Company Details
Table 144. ABMD Business Overview
Table 145. ABMD Stem Cells Product
Table 146. ABMD Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 147. ABMD Recent Development
Table 148. Stem Cells Market Trends
Table 149. Stem Cells Market Drivers
Table 150. Stem Cells Market Challenges
Table 151. Stem Cells Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cells Product Picture
Figure 2. Global Stem Cells Market Share by Type: 2024 VS 2031
Figure 3. Stem Cell Storage Features
Figure 4. Stem Cell Pharmaceutical and Treatment Features
Figure 5. Global Stem Cells Market Share by Application: 2024 VS 2031
Figure 6. Blood Disease
Figure 7. Cancer
Figure 8. Autoimmune Disease
Figure 9. Others
Figure 10. Stem Cells Report Years Considered
Figure 11. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Stem Cells Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Stem Cells Market Share by Players in 2024
Figure 19. Global Top Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Stem Cells Revenue in 2024
Figure 21. North America Stem Cells Market Share by Type (2020-2025)
Figure 22. North America Stem Cells Market Share by Application (2020-2025)
Figure 23. Europe Stem Cells Market Share by Type (2020-2025)
Figure 24. Europe Stem Cells Market Share by Application (2020-2025)
Figure 25. China Stem Cells Market Share by Type (2020-2025)
Figure 26. China Stem Cells Market Share by Application (2020-2025)
Figure 27. Japan Stem Cells Market Share by Type (2020-2025)
Figure 28. Japan Stem Cells Market Share by Application (2020-2025)
Figure 29. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 30. NuVasive Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 31. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 32. Medi-post Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 33. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 34. MolMed Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 35. Pharmicell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 36. Anterogen Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 37. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 38. CBR Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 39. ViaCord Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 40. Esperite Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 41. LifeCell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 42. CCBC Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 43. VCANBIO Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 44. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 45. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 46. International Medical Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 47. Global Cord Blood Corporation Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 48. Beijing Health-Biotech Group Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 49. ABMD Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Stem Cells Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Stem Cells Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Stem Cells Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Stem Cells Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Stem Cells Revenue Share by Region (2020-2025)
Table 6. Global Stem Cells Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Stem Cells Revenue Share Forecast by Region (2026-2031)
Table 8. Global Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Stem Cells Revenue Market Share by Type (2020-2025)
Table 10. Global Stem Cells Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Stem Cells Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Stem Cells Revenue Market Share by Application (2020-2025)
Table 15. Global Stem Cells Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Stem Cells Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Stem Cells Application
Table 18. Global Stem Cells Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Stem Cells Market Share by Players (2020-2025)
Table 20. Global Top Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Table 21. Ranking of Global Top Stem Cells Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Stem Cells Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Stem Cells, Headquarters and Area Served
Table 24. Global Key Players of Stem Cells, Product and Application
Table 25. Global Key Players of Stem Cells, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Stem Cells Revenue Market Share by Company (2020-2025)
Table 29. North America Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Stem Cells Revenue Market Share by Company (2020-2025)
Table 33. Europe Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Stem Cells Revenue Market Share by Company (2020-2025)
Table 37. China Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Stem Cells Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Stem Cells Revenue Market Share by Company (2020-2025)
Table 41. Japan Stem Cells Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Stem Cells Market Size by Application (2020-2025) & (US$ Million)
Table 43. Osiris Therapeutics Company Details
Table 44. Osiris Therapeutics Business Overview
Table 45. Osiris Therapeutics Stem Cells Product
Table 46. Osiris Therapeutics Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 47. Osiris Therapeutics Recent Development
Table 48. NuVasive Company Details
Table 49. NuVasive Business Overview
Table 50. NuVasive Stem Cells Product
Table 51. NuVasive Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 52. NuVasive Recent Development
Table 53. Chiesi Pharmaceuticals Company Details
Table 54. Chiesi Pharmaceuticals Business Overview
Table 55. Chiesi Pharmaceuticals Stem Cells Product
Table 56. Chiesi Pharmaceuticals Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 57. Chiesi Pharmaceuticals Recent Development
Table 58. Medi-post Company Details
Table 59. Medi-post Business Overview
Table 60. Medi-post Stem Cells Product
Table 61. Medi-post Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 62. Medi-post Recent Development
Table 63. JCR Pharmaceutical Company Details
Table 64. JCR Pharmaceutical Business Overview
Table 65. JCR Pharmaceutical Stem Cells Product
Table 66. JCR Pharmaceutical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 67. JCR Pharmaceutical Recent Development
Table 68. MolMed Company Details
Table 69. MolMed Business Overview
Table 70. MolMed Stem Cells Product
Table 71. MolMed Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 72. MolMed Recent Development
Table 73. Pharmicell Company Details
Table 74. Pharmicell Business Overview
Table 75. Pharmicell Stem Cells Product
Table 76. Pharmicell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 77. Pharmicell Recent Development
Table 78. Anterogen Company Details
Table 79. Anterogen Business Overview
Table 80. Anterogen Stem Cells Product
Table 81. Anterogen Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 82. Anterogen Recent Development
Table 83. Takeda (TiGenix) Company Details
Table 84. Takeda (TiGenix) Business Overview
Table 85. Takeda (TiGenix) Stem Cells Product
Table 86. Takeda (TiGenix) Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 87. Takeda (TiGenix) Recent Development
Table 88. CBR Company Details
Table 89. CBR Business Overview
Table 90. CBR Stem Cells Product
Table 91. CBR Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 92. CBR Recent Development
Table 93. ViaCord Company Details
Table 94. ViaCord Business Overview
Table 95. ViaCord Stem Cells Product
Table 96. ViaCord Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 97. ViaCord Recent Development
Table 98. Esperite Company Details
Table 99. Esperite Business Overview
Table 100. Esperite Stem Cells Product
Table 101. Esperite Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 102. Esperite Recent Development
Table 103. LifeCell Company Details
Table 104. LifeCell Business Overview
Table 105. LifeCell Stem Cells Product
Table 106. LifeCell Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 107. LifeCell Recent Development
Table 108. CCBC Company Details
Table 109. CCBC Business Overview
Table 110. CCBC Stem Cells Product
Table 111. CCBC Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 112. CCBC Recent Development
Table 113. VCANBIO Company Details
Table 114. VCANBIO Business Overview
Table 115. VCANBIO Stem Cells Product
Table 116. VCANBIO Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 117. VCANBIO Recent Development
Table 118. BOYA LIFE Company Details
Table 119. BOYA LIFE Business Overview
Table 120. BOYA LIFE Stem Cells Product
Table 121. BOYA LIFE Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 122. BOYA LIFE Recent Development
Table 123. Beike Biotechnology Company Details
Table 124. Beike Biotechnology Business Overview
Table 125. Beike Biotechnology Stem Cells Product
Table 126. Beike Biotechnology Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 127. Beike Biotechnology Recent Development
Table 128. International Medical Company Details
Table 129. International Medical Business Overview
Table 130. International Medical Stem Cells Product
Table 131. International Medical Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 132. International Medical Recent Development
Table 133. Global Cord Blood Corporation Company Details
Table 134. Global Cord Blood Corporation Business Overview
Table 135. Global Cord Blood Corporation Stem Cells Product
Table 136. Global Cord Blood Corporation Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 137. Global Cord Blood Corporation Recent Development
Table 138. Beijing Health-Biotech Group Company Details
Table 139. Beijing Health-Biotech Group Business Overview
Table 140. Beijing Health-Biotech Group Stem Cells Product
Table 141. Beijing Health-Biotech Group Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 142. Beijing Health-Biotech Group Recent Development
Table 143. ABMD Company Details
Table 144. ABMD Business Overview
Table 145. ABMD Stem Cells Product
Table 146. ABMD Revenue in Stem Cells Business (2020-2025) & (US$ Million)
Table 147. ABMD Recent Development
Table 148. Stem Cells Market Trends
Table 149. Stem Cells Market Drivers
Table 150. Stem Cells Market Challenges
Table 151. Stem Cells Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Stem Cells Product Picture
Figure 2. Global Stem Cells Market Share by Type: 2024 VS 2031
Figure 3. Stem Cell Storage Features
Figure 4. Stem Cell Pharmaceutical and Treatment Features
Figure 5. Global Stem Cells Market Share by Application: 2024 VS 2031
Figure 6. Blood Disease
Figure 7. Cancer
Figure 8. Autoimmune Disease
Figure 9. Others
Figure 10. Stem Cells Report Years Considered
Figure 11. Global Stem Cells Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Stem Cells Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Stem Cells Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Stem Cells Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Stem Cells Market Share by Players in 2024
Figure 19. Global Top Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cells as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Stem Cells Revenue in 2024
Figure 21. North America Stem Cells Market Share by Type (2020-2025)
Figure 22. North America Stem Cells Market Share by Application (2020-2025)
Figure 23. Europe Stem Cells Market Share by Type (2020-2025)
Figure 24. Europe Stem Cells Market Share by Application (2020-2025)
Figure 25. China Stem Cells Market Share by Type (2020-2025)
Figure 26. China Stem Cells Market Share by Application (2020-2025)
Figure 27. Japan Stem Cells Market Share by Type (2020-2025)
Figure 28. Japan Stem Cells Market Share by Application (2020-2025)
Figure 29. Osiris Therapeutics Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 30. NuVasive Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 31. Chiesi Pharmaceuticals Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 32. Medi-post Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 33. JCR Pharmaceutical Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 34. MolMed Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 35. Pharmicell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 36. Anterogen Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 37. Takeda (TiGenix) Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 38. CBR Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 39. ViaCord Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 40. Esperite Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 41. LifeCell Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 42. CCBC Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 43. VCANBIO Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 44. BOYA LIFE Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 45. Beike Biotechnology Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 46. International Medical Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 47. Global Cord Blood Corporation Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 48. Beijing Health-Biotech Group Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 49. ABMD Revenue Growth Rate in Stem Cells Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232